EN DE
Watch HGH HOLDINGS LTD. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

HGH HOLDINGS LTD. (5GZ) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of HGH HOLDINGS LTD. stock S$0.02, price S$0.02, upside +55.0%, quality 58 out of 100. Rating: strongly undervalued. Calculated from audited financials with 15 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials SG · ISIN SG1S12926576

HH HGH HOLDINGS LTD. logo Thin data Nov 16, 2026

HGH HOLDINGS LTD.

5GZ · SG

Cheap (35% below fair value) and solid company, but falling price: meets 2 of 3 rules.

Get notified free when this changes
Fair value 0.0233 SGD · Strongly undervalued 
Solidly profitable · 10.6% net margin (TTM) 
Low debt 
Ranks above peers (11/11) 
Last quarter vs. a year ago: revenue +91%, profit +160%. 
Quality 58/100 
Expensive Growth (revenue 5y +36.1 %/yr in SGD) 
Moderate moat 50/100
Falling price (downtrend) 
Negative free cash flow 
Thin data 
Watch HGH HOLDINGS LTD. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

0.0320 SGD 0.0090 SGD Fair Value 0.0233 SGD Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.

How to read this chart

60‑month range 0.0090 SGD – 0.0320 SGD · fair‑value band 0.0188 SGD – 0.0263 SGD · the 0.0150 SGD price screens below the 0.0233 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.

Follow HGH HOLDINGS in your weekly email

Every Wednesday you see whether HGH HOLDINGS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

HGH Holdings Ltd., an investment holding company, provides leasing and services in Singapore and Malaysia.

Show moreShow less

The company operates through four segments: Leasing and Service Income; Manufacturing of Precast Concrete Products; Supply and Manufacturing of Ready-Mix Concrete Products; and Provision of Underground Cable Installation and Road Reinstatement.

It also provides general warehousing and logistics services; supplies precast concrete products; and industrial and office spaces for engineering, manufacturing, and industrial training and workers' dormitory facilities.

In addition, the company offers structural and non-structural precast concrete products for civil and construction works, as well as for civil engineering contractors.

Further, it provides underground cable installation comprising the installation of power cables, auxiliary cables, and other accessories under the ground; ready-mix concrete; and road reinstatement, including the backfilling and reinstatement of road surfaces, as well as business and management consultancy and other business support services.

HGH Holdings Ltd. was founded in 1995 and is based in Singapore.

Stock analysis

HGH HOLDINGS LTD. (5GZ) currently trades at 0.0150 SGD, while our model-based Fair Value estimate is 0.0233 SGD, implying the stock looks roughly 35% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 0.0900 SGD per share, and 14 of the 15 models we run sit above the 0.0150 SGD price.

Bear case: the Asset-Based group reads lowest at 0.0200 SGD, and 1 of the 15 models stay below the price. Data coverage for this calculation is low.

Scenario range: 0.0188 SGD (bear) to 0.0263 SGD (bull), the price of 0.0150 SGD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 58/100 (solid quality), in the Industrials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

HGH HOLDINGS LTD. reported revenue of 54.6M SGD in FY2025 versus 20.1M SGD in FY2021, a compound +28.5%/yr. Reported net income was 5.2M SGD in FY2025.

Key figures

Market cap 26.7M SGD (≈ $20.7M) Micro · P/S ratio 0.35 · Net margin 9.6% · Return on equity 16.0% · Return on assets (EBIT) −0.2% (5-year average) · Operating margin 13.3% · Revenue (TTM) 76.5M SGD · Revenue growth (YoY) +90.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (medium confidence).

What moves the price

The share trades about 46% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −12% fair-value upside, at 55%, 5GZ screens cheaper than that median.

Fair Value models

Bear 0.0188 SGD Fair Value 0.0233 SGD Bull 0.0263 SGD
Price 0.0150 SGD · Upside +55.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV 0.0400 SGD 0.0400 SGD 0.0500 SGD 74
ROIC Compounder 0.0400 SGD 0.0700 SGD 0.0800 SGD 72
Residual Income 0.0300 SGD 0.0300 SGD 0.0400 SGD 71
All 15 models by family
DCF Models
Owner Earnings 0.0300 SGD 0.0700 SGD 0.1600 SGD 69
Earnings-Based
Graham-Dodd 0.0200 SGD 0.1400 SGD 0.2000 SGD 63
Lynch FV 0.0500 SGD 0.0700 SGD 0.0900 SGD 61
PEG = 1.0 0.0500 SGD 0.0700 SGD 0.0900 SGD 57
EPV 0.0400 SGD 0.0400 SGD 0.0500 SGD 74
Multiples
P/E Multiple 0.0500 SGD 0.0600 SGD 0.0800 SGD 63
P/S Multiple 0.0400 SGD 0.0500 SGD 0.0600 SGD 58
P/B Multiple 0.0100 SGD 0.0100 SGD 0.0200 SGD 52
EV/EBIT 0.0500 SGD 0.0700 SGD 0.0800 SGD 66
EV/EBITDA 0.0700 SGD 0.0900 SGD 0.1100 SGD 67
EV/Revenue 0.0400 SGD 0.0500 SGD 0.0700 SGD 53
Asset-Based
NCAV (Graham) 0.0100 SGD 0.0200 SGD 0.0300 SGD 52
Economic Profit
Residual Income 0.0300 SGD 0.0300 SGD 0.0400 SGD 71
ROIC Compounder 0.0400 SGD 0.0700 SGD 0.0800 SGD 72
Growth Earnings
Growth-Adj P/E 0.0600 SGD 0.0900 SGD 0.1100 SGD 68

Open the full fair value analysis →

Quality Score breakdown

Overall quality 58/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 40
How much profit the company makes from its sales and capital
Quality Growth 79
Are margins and returns getting better?
Cashflow 6
Do the profits arrive as real cash?
Financial strength 67
Debt, balance sheet and risk of trouble
Investment 72
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 17
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+156.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+36.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+36.1%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−15.1% (2020) → 11.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

Watch 5GZ, get fair value alerts →

Compare HGH HOLDINGS LTD. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Electrical Equipment & Parts · 599 stocks

Beats the industry median on 10/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 58 · Above median
Fair Value upside +55.3% · Top 25%
Profitability
Return on equity (12 months) 16.0% · Top 25%
Return on assets 5.7% · Above median
Net margin (12 months) 10.6% · Top 25%
Operating margin (12 months) 13.3% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 90.5% · Top 25%

Valuation Multiplesvs Electrical Equipment & Parts median · lower = cheaper

P/B 0.52× · Cheapest 25%
P/S (12 months) 0.35× · Cheapest 25%
EV/EBITDA 1.3× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 0
FUTURE (revenue growth)100 · sector 72
PAST (return on equity)64 · sector 25
HEALTH (low debt)100 · sector 97
DIVIDEND (yield)0 · sector 24

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Electrical Equipment & Parts stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Contemporary Amperex Technology Co 300750 ¥240.50 ¥648.35 +170% vs 5GZ
Sungrow Power Supply Co 300274 ¥75.81 ¥182.32 +141% vs 5GZ
NARI Technology Co 600406 ¥24.19 ¥29.39 +22% vs 5GZ
Samsung SDI Co 006400 462,500 KRW 410,592 KRW −11% vs 5GZ
Vertiv Holdings VRT $202.07 $178.64 −12% vs 5GZ
Legrand SA LR €135.20 €82.49 −39% vs 5GZ
Prysmian S.p.A PRY €107.65 €64.29 −40% vs 5GZ
ABB Ltd ABBN CHF 69.22 CHF 30.27 −56% vs 5GZ
Delta Electronics (Thailand) Public Company DELTA 185.50 THB 39.14 THB −79% vs 5GZ
LG Energy Solution, Ltd 373220 318,500 KRW 53,325 KRW −83% vs 5GZ

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

HGH HOLDINGS LTD.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "HGH HOLDINGS LTD. Fair Value". https://www.fairvalue-calculator.com/stock/5GZ

Frequently asked questions

Is HGH HOLDINGS LTD. (5GZ) overvalued or undervalued?
As of Nov 16, 2026, our model estimates a fair value of 0.0233 SGD versus a price of 0.0150 SGD, about +55% upside (undervalued).
What is the fair value of 5GZ?
Our model-based fair value for HGH HOLDINGS LTD. is 0.0233 SGD (as of Nov 16, 2026), built from audited fundamentals. The current price: 0.0150 SGD.
What is the quality score of 5GZ?
HGH HOLDINGS LTD. has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for HGH HOLDINGS LTD. (5GZ)?
Our model-based price target is the fair value of 0.0233 SGD (as of Nov 16, 2026) from 15 valuation models. Cautious scenario 0.0188 SGD, optimistic scenario 0.0263 SGD. It is a calculation from audited fundamentals, not an analyst target.
What is the HGH HOLDINGS LTD. stock forecast for 2026?
Our models put fair value at 0.0233 SGD, about +55% upside versus a price of 0.0150 SGD (undervalued). Cautious scenario 0.0188 SGD, optimistic scenario 0.0263 SGD. The calculation is refreshed regularly with new filings.
What is the revenue of HGH HOLDINGS LTD. (5GZ)?
HGH HOLDINGS LTD. reported trailing-twelve-month revenue of about 76.5M SGD (latest available figure, as of Nov 16, 2026).
What is the intrinsic value of HGH HOLDINGS LTD. (5GZ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For HGH HOLDINGS LTD. it is 0.0233 SGD per share (as of Nov 16, 2026), against a price of 0.0150 SGD. It is the blended result of 15 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is HGH HOLDINGS LTD. stock overvalued or undervalued in 2026?
As of Nov 16, 2026, 5GZ trades below its calculated fair value: price 0.0150 SGD, fair value 0.0233 SGD, a gap of about +55% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 5GZ?
No. The price is what the market pays today (0.0150 SGD); the fair value is what the company's own numbers justify (0.0233 SGD). For HGH HOLDINGS LTD. the two are 0.0083 SGD per share apart. That gap is exactly why we show both numbers side by side.
How much is HGH HOLDINGS LTD. worth?
The market values HGH HOLDINGS LTD. at about 26.7M SGD (market capitalisation, as of Nov 16, 2026). Per share that is 0.0150 SGD; our models calculate a fair value of 0.0233 SGD per share.
What do the bullish and bearish scenarios say about 5GZ?
Our models span a range for HGH HOLDINGS LTD.: cautious scenario 0.0188 SGD, base 0.0233 SGD, optimistic 0.0263 SGD per share (as of Nov 16, 2026, price 0.0150 SGD). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of HGH HOLDINGS LTD. (5GZ)?
Balance-sheet figures for HGH HOLDINGS LTD. (as of Nov 16, 2026): return on equity 16.0%. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is 5GZ from its 52-week high?
HGH HOLDINGS LTD. trades at 0.0150 SGD, about 46% below its 52-week high of 0.0280 SGD and at the low of 0.0150 SGD (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of 0.0233 SGD is for.
Which stocks are comparable to HGH HOLDINGS LTD.?
From the same area (Industrials) we also value Contemporary Amperex Technology Co, ABB Ltd, Vertiv Holdings, Delta Electronics (Thailand) Public Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is HGH HOLDINGS LTD. stock attractive at the current price?
The data as of Nov 16, 2026: price 0.0150 SGD, calculated fair value 0.0233 SGD (+55%), Quality Score 58/100, from 15 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 5GZ calculated?
We run HGH HOLDINGS LTD. through 15 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 0.0233 SGD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. HGH HOLDINGS LTD. currently trades 35% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of HGH HOLDINGS LTD. (5GZ)?
The closing price on Nov 10, 2026 was 0.0150 SGD. Our model-based fair value is 0.0233 SGD, about +55% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with HGH HOLDINGS LTD. right now?
The price is below even our cautious bear case (0.0188 SGD). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (58/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of HGH HOLDINGS LTD.

How large is the market capitalisation of HGH HOLDINGS LTD. (5GZ)?
The market capitalisation of HGH HOLDINGS LTD. is 26.7M SGD (≈ $20.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of HGH HOLDINGS LTD. (5GZ)?
The price-to-sales ratio of HGH HOLDINGS LTD. is 0.35 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of HGH HOLDINGS LTD. (5GZ)?
The net margin of HGH HOLDINGS LTD. is 9.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of HGH HOLDINGS LTD. (5GZ)?
The return on equity (ROE) of HGH HOLDINGS LTD. is 16.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of HGH HOLDINGS LTD. (5GZ)?
On an EBIT basis the return on assets of HGH HOLDINGS LTD. is −0.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of HGH HOLDINGS LTD. (5GZ)?
The operating margin of HGH HOLDINGS LTD. is 13.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at HGH HOLDINGS LTD. (5GZ)?
Revenue at HGH HOLDINGS LTD. is growing 90.5% versus a year earlier (3y avg +36.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at HGH HOLDINGS LTD. (5GZ)?
Earnings per share at HGH HOLDINGS LTD. are growing 160% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does HGH HOLDINGS LTD. (5GZ) generate?
The free cash flow of HGH HOLDINGS LTD. is −3.1M SGD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch HGH HOLDINGS LTD. in the live analysis

One click puts HGH HOLDINGS LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.